BGJ398 for Patients With Tumors With FGFR Genetic Alterations

Summary

The purpose of this signal seeking study was to determine whether treatment with BGJ398 demonstrates sufficient efficacy in select FGFR pathway-regulated solid tumors and/or hematologic malignancies to warrant further study.

Timeline

Start

2014-07-24

Primary completion

2018-04-30

Completion

2018-04-30

Drugs

Indications